Bluu Biosciences appoints Chris Dammann as inaugural Chief Operating Officer

August 19, 2021 - 3 min read

From left, Bluu Biosciences executive team: COO Chris Dammann; Co-Founder and Managing Director Dr Sebastian Rakers; Co-Founder and Managing Director Simon Fabich. Copyright Bluu GmbH. From left, Bluu Biosciences executive team: COO Chris Dammann; Co-Founder and Managing Director Dr Sebastian Rakers; Co-Founder and Managing Director Simon Fabich. Copyright Bluu GmbH.

Europe's first company for cultivated fish onboards renowned expert to speed up large-scale production of cultivated fish products.

Berlin, August 19th, 2021. Bluu Biosciences, pioneer in the development and production of cultivated fish in Europe, has appointed Chris Dammann as the company’s first COO. He is considered one of the world's leading experts in cellular agriculture and cultivated fish development. A native German, Chris traded Europe for the U.S. early in his career and looks back on many years of experience in research, management, R&D operations, product development and intellectual property.

Prior to joining Bluu Biosciences Chris co-founded BlueNalu, one of the first companies worldwide to specialize in cultivated seafood. He developed the technology strategy and scientific approach for the company, and as its CTO led the implementation of a technology platform for cultivated fish. He built and led the R&D team, while also managing collaborations, IP, IT, and the establishment of a PMO. Before founding BlueNalu Chris was Director of Science & Technology at the Invention Development Fund of Intellectual Ventures. Other career stops include the role of Sr. Scientist at BASF and multiple engagements as an independent consultant focusing on tissue engineering, genomics, and intellectual property. Chris holds a Ph.D. in Molecular Biology & Genetics from the Free University of Berlin, Germany.

As COO at Bluu Biosciences, Chris will leverage his extensive know-how and knowledge of the industry to ensure that the most effective and efficient processes are implemented throughout the company. He will be responsible for key areas including commercialization efforts, scale-up strategy, collaboration management and IP.

"With Chris, we have been able to attract a first-class expert and innovation leader in cultivated fish to Bluu Biosciences. With his extensive knowledge and experience as a founder, he is a valuable addition to our leadership team. We are very pleased to welcome an entrepreneur on board, who shares our values and our ambition to revolutionize fish production," explained Dr Sebastian Rakers, co-founder of Bluu Biosciences in partnership with Simon Fabich.

Chris Dammann emphasized: "Bluu Biosciences has the scientific excellence, technical concept and entrepreneurial vision that an innovative start-up needs to become a competitive and successful company in the global market. Bluu Biosciences’ approach is unique, and I am very excited to use my experience to guide the first cultivated fish company in Europe towards market readiness."

About Bluu GmbH (Bluu Biosciences)

Bluu Biosciences is the first company in Europe to specialize in the development and commercial production of cultivated fish. As a pioneer at the interface of biotechnology and food technology, Bluu Biosciences is stepping up to produce high-quality, sustainable fish products from cell cultures, that feature high nutritional value and a premium flavour profile. The aim is to produce fish sustainably and cost-efficiently, thus making a significant contribution to securing the future supply of animal protein for mankind. The company, based in Berlin and Lübeck, was founded in 2020 by Dr Sebastian Rakers and Simon Fabich with an expert team of marine biologists, cell biologists, tissue engineers, and food technologists. In R&D, Bluu Biosciences closely cooperates with the Fraunhofer Research Institution for Marine Biotechnology and Cell Engineering (EMB) in Lübeck and has access to state-of-the-art R&D installations. More information at

Event Partners